| Financial Year |
December 31 2020 |
| Monetary Funds |
46,973,930.91 |
| Held-for-trading Financial Assets |
56,915,592.12 |
| Notes Receivable |
2,261,096.53 |
| Accounts Receivable |
85,609,794.12 |
| Advances to Suppliers |
4,016,702.43 |
| Other Receivables |
4,720,987.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
62,630,310.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,470,210.36 |
| Total Current Assets |
265,481,628.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
104,216,665.54 |
| Under-construction Projects |
8,590,583.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,200,880.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,019,212.66 |
| Deferred Income Tax Assets |
1,884,515.97 |
| Other Non-Current Assets |
1,485,405.98 |
| Sub-Total of Non-Current Assets |
176,397,264.30 |
| Total Assets |
441,878,892.63 |
| Short-Term Loans |
135,717.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,639,750.15 |
| Accounts Payable |
73,454,216.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,916,190.74 |
| Taxes Payable |
2,204,562.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,109,746.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,270,882.10 |
| Sub-Total of Current Liabilities |
115,332,081.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,381,794.80 |
| Deferred Income Tax Liabilities |
4,334,169.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,934,105.88 |
| Total Liabilities |
125,266,187.05 |
| Paid-In Capital(Or Share Stock) |
60,000,000.00 |
| Capital Surplus |
139,613,594.37 |
| Surplus Reserve |
13,566,718.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
104,602,344.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
316,612,705.58 |
| Owner's Equity（Stockholder's Equity） |
316,612,705.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
441,878,892.63 |
